Literature DB >> 20198582

Molecular cloning and expression of epsilon toxin from Clostridium perfringens type D and tests of animal immunization.

A M Souza1, J K P Reis, R A Assis, C C Horta, F F Siqueira, S Facchin, E R Alvarenga, C S Castro, F M Salvarani, R O S Silva, P S Pires, C Contigli, F C F Lobato, E Kalapothakis.   

Abstract

Epsilon toxin produced by Clostridium perfringens types B and D causes enterotoxemia in sheep, goats and calves. Enterotoxemia can cause acute or superacute disease, with sudden death of the affected animal. It provokes huge economic losses when large numbers of livestock are affected. Therapeutic intervention is challenging, because the disease progresses very rapidly. However, it can be prevented by immunization with specific immunogenic vaccines. We cloned the etx gene, encoding epsilon toxin, into vector pET-11a; recombinant epsilon toxin (rec-epsilon) was expressed in inclusion bodies and was used for animal immunization. Serum protection was evaluated and cross-serum neutralization tests were used to characterize the recombinant toxin. To analyze the potency of the toxin (as an antigen), rabbits were immunized with 50, 100 or 200 microg recombinant toxin, using aluminum hydroxide gel as an adjuvant. Titers of 10, 30 and 40 IU/mL were obtained, respectively. These titers were higher than the minimum level required by the European Pharmacopoeia (5 IU/mL) and by the USA Code of Federal Regulation (2 IU/mL). This rec-epsilon is a good candidate for vaccine production against enterotoxemia caused by epsilon toxin of C. perfringens type D.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198582     DOI: 10.4238/vol9-1gmr711

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  12 in total

1.  A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.

Authors:  Qing Li; Wenwen Xin; Shan Gao; Lin Kang; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

2.  Production, immunogenicity, stability, and safety of a vaccine against Clostridium perfringens beta toxins.

Authors:  Mohamed J Saadh; Issam J Sa'adeh; Moeen F Dababneh; Ammar M Almaaytah; Mohammad F Bayan
Journal:  Vet World       Date:  2020-08-07

Review 3.  Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines.

Authors:  Marcos Roberto A Ferreira; Gustavo Marçal S G Moreira; Carlos Eduardo P da Cunha; Marcelo Mendonça; Felipe M Salvarani; Ângela N Moreira; Fabricio R Conceição
Journal:  Toxins (Basel)       Date:  2016-11-21       Impact factor: 4.546

4.  Cloning and expression of Clostridium perfringens type D vaccine strain epsilon toxin gene in E. coli as a recombinant vaccine candidate.

Authors:  Parastoo Aziminia; Reza Pilehchian-Langroudi; Kasra Esmaeilnia
Journal:  Iran J Microbiol       Date:  2016-08

5.  Mapping of the continuous epitopes displayed on the Clostridium perfringens type D epsilon-toxin.

Authors:  Guilherme Guerra Alves; Ricardo Andrez Machado-de-Ávila; Carlos Delfin Chávez-Olórtegui; Rodrigo Otávio Silveira Silva; Francisco Carlos Faria Lobato
Journal:  Braz J Microbiol       Date:  2017-02-03       Impact factor: 2.476

6.  Evaluation of plant-produced <i>Clostridium perfringens</i> type D <i>epsilon</i> toxoid in a vaccine against enterotoxaemia in sheep.

Authors:  Tinyiko Mokoena; Ereck Chakauya; Michael Crampton; Boet Weyers; Malefa Tselanyane; Tsepo Tsekoa; Rachel Chikwamba
Journal:  Onderstepoort J Vet Res       Date:  2017-04-25       Impact factor: 1.792

7.  Phenotypic detection and genotyping of Clostridium perfringens associated with enterotoxemia in sheep in the Qassim Region of Saudi Arabia.

Authors:  Fehaid Alsaab; Ali Wahdan; Elhassan M A Saeed
Journal:  Vet World       Date:  2021-03-06

8.  Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.

Authors:  Kareem Rashid Rumah; Jennifer Linden; Vincent A Fischetti; Timothy Vartanian
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

9.  Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.

Authors:  Gustavo Marçal Schmidt Garcia Moreira; Felipe Masiero Salvarani; Carlos Eduardo Pouey da Cunha; Marcelo Mendonça; Ângela Nunes Moreira; Luciana Aramuni Gonçalves; Prhiscylla Sadanã Pires; Francisco Carlos Faria Lobato; Fabricio Rochedo Conceição
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

10.  Measurement over 1 Year of Neutralizing Antibodies in Cattle Immunized with Trivalent Vaccines Recombinant Alpha, Beta and Epsilon of Clostridium perfringens.

Authors:  Cleideanny C Galvão; José D Barbosa; Carlos M C Oliveira; Denis Y Otaka; Paulo R O Silva; Marcos R A Ferreira; Clóvis Moreira Júnior; Fabricio R Conceição; Felipe M Salvarani
Journal:  Toxins (Basel)       Date:  2021-08-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.